Amedisys Inc. has completed a merger, resulting in the termination of its Amended and Restated Credit Agreement from June 29, 2018. The company satisfied its outstanding obligations under the Senior Credit Facilities by paying approximately $399.2 million. As part of the merger agreement, each share of Amedisys common stock was converted into the right to receive $101 in cash, excluding any shares held as treasury stock or owned by UnitedHealth Group or its subsidiaries. Additionally, Amedisys equity awards were converted into restricted stock unit awards of the parent company, with adjustments to reflect the merger consideration.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amedisys Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-078145), on August 14, 2025, and is solely responsible for the information contained therein.